Alternative Intravenous Dextrose Regimen for Unconscious Adults
For unconscious or unable-to-swallow adults with hypoglycemia, administer 10-25 grams of intravenous dextrose, with 10% dextrose solution given in 5-gram aliquots being the preferred alternative to the traditional 50% dextrose bolus. 1
Recommended Dosing Protocols
Primary Recommendation: 10% Dextrose in Aliquots
- Administer 50 mL (5 grams) of 10% dextrose IV over 1 minute 2
- Repeat every 1-2 minutes until Glasgow Coma Scale reaches 15 or patient is alert 3, 2
- Maximum total dose: 25 grams (250 mL of 10% solution)
- Expected time to recovery: 6-8 minutes 3, 2
Alternative: 25% Dextrose Solution
- Administer 20 mL (5 grams) of 25% dextrose IV over 1 minute 3
- Repeat as needed with same parameters as 10% solution
- Similar efficacy to 10% with intermediate concentration
Traditional Approach: 50% Dextrose
- FDA-approved dose: 20-50 mL (10-25 grams) of 50% dextrose 1
- Administer slowly to avoid complications
- Higher risk of post-treatment hyperglycemia and adverse events 4, 2
Why Lower Concentration Dextrose is Superior
The evidence strongly favors 10% dextrose over 50% dextrose based on multiple studies:
- Lower post-treatment glucose levels: 10% dextrose results in median blood glucose of 6.2 mmol/L versus 9.4 mmol/L with 50% dextrose 2
- Fewer adverse events: Zero adverse events reported with 10% (0/1057 patients) compared to 13/310 with 50% 4
- Smaller total dose required: Median 10 grams with 10% versus 25 grams with 50% 2
- Equal symptom resolution: 95.9% with 10% versus 88.8% with 50% 4
- Similar time to recovery: Only 4 minutes longer (8 minutes vs 4 minutes) 4
Monitoring and Follow-Up
After initial dextrose administration:
- Recheck blood glucose every 1-2 minutes until patient alert 5
- Approximately 18-26% of patients require a second dose 3, 6
- Once conscious and able to swallow, provide 15-20 grams oral glucose followed by protein-containing snack 7, 8
- Continue monitoring for recurrent hypoglycemia
Critical Pitfalls to Avoid
Overcorrection with 50% dextrose: The traditional 25-gram bolus of 50% dextrose frequently causes excessive hyperglycemia (median 169 mg/dL post-treatment), which may contribute to neuronal injury 5. The titrated approach with lower concentrations prevents this.
Extravasation risk: While no extravasation injuries were reported in comparative studies 2, the hypertonic nature of 50% dextrose theoretically poses greater tissue damage risk if IV infiltrates.
Delayed recognition of treatment failure: If no response after 15 minutes of dextrose administration, immediately activate emergency medical services and consider glucagon 1 mg IM/SC 9, 7. This suggests alternative pathology or need for advanced care.
Special Circumstances
For patients on alpha-glucosidase inhibitors: Standard dextrose protocols remain appropriate, as IV glucose bypasses intestinal absorption 7
Prolonged hypoglycemia (e.g., sulfonylurea overdose): May require continuous dextrose infusion rather than boluses, with hospitalization for extended monitoring 8
Practical supply considerations: The 10% dextrose protocol addresses ongoing D50 shortages and is more cost-effective 6, 10